Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer

被引：96

作者：

Sadoff, Jerald ^{[1
]}

Davis, Kourtney ^{[1
]}

Douoguih, Macaya ^{[1
]}

机构：

[1] Janssen Vaccines & Prevent, Leiden, Netherlands

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 20期

关键词：

D O I：

10.1056/NEJMc2106075

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Manufacturer's Response The manufacturer of the Ad26.COV2.S vaccine against Covid-19 comments on recent reports of thrombosis, including cerebral venous sinus thrombosis, associated with severe thrombocytopenia in several recipients of the vaccine.

引用

页码：1965 / 1966

页数：2

共 5 条

[1] Cerebral venous sinus thrombosis [J].

Capecchi, M. ;

Abbattista, M. ;

Martinelli, I. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) :1918-1931

[2]

Centers for Disease Control and Prevention, 2021, COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19, DOI DOI 10.30595/MEDISAINS.V19I2.11661

[3]

European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, 2021, ACCESS BACKGR INC RA

[4]

Food and Drug Administration, 2021, JOINT MED CALL FDA C

[5] Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination [J].

Muir, Kate-Lynn ;

Kallam, Avyakta ;

Koepsell, Scott A. ;

Gundabolu, Krishna .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1964-1965

← 1 →